Difference between revisions of "Molecular Pathology Rotation Notes"
Jump to navigation
Jump to search
(Created page with "===UNIT 1=== {{hidden|List three differences between DNA and RNA.|DNA (double stranded, thymine, deoxyribose, more stable; RNA single stranded, ribose, uracil}} {{hidden...") |
|||
Line 51: | Line 51: | ||
{{hidden|Describe briefly Sanger sequencing.|<center>[[DIdeoxynucleotides are used in a mix with deoxynucleotides, the Di*** terminate the chain, and so you get all possible lengths of chains so then you put them all in order and you can read (based on weight) which one is at each position]]</center>}} | {{hidden|Describe briefly Sanger sequencing.|<center>[[DIdeoxynucleotides are used in a mix with deoxynucleotides, the Di*** terminate the chain, and so you get all possible lengths of chains so then you put them all in order and you can read (based on weight) which one is at each position]]</center>}} | ||
{{hidden|Describe briefly how Taqman automated genotyping is used for allele detection. |<center>[[ | {{hidden|Describe briefly how Taqman automated genotyping is used for allele detection. |<center>[[]]</center>}} | ||
{{hidden|How are DNA microarrays used to identify drug disposition or responses?|<center>[[ | {{hidden|How are DNA microarrays used to identify drug disposition or responses?|<center>[[]]</center>}} | ||
===UNIT 4=== | ===UNIT 4=== | ||
{{hidden|Describe the procedure for submitting FFPE slides for KRAS for colorectal cancer.|<center>[[ | {{hidden|Describe the procedure for submitting FFPE slides for KRAS for colorectal cancer.|<center>[[]]</center>}} | ||
{{hidden|Compare and contrast uniplex versus multiplex genotyping. |<center>[[ | {{hidden|Compare and contrast uniplex versus multiplex genotyping. |<center>[[]]</center>}} | ||
{{hidden|Compare and contrast conventional vs massively parallel sequencing. |<center>[[ | {{hidden|Compare and contrast conventional vs massively parallel sequencing. |<center>[[]]</center>}} | ||
{{hidden|What is multiplex ligation-dependent ligation (MLPA)?|<center>[[ | {{hidden|What is multiplex ligation-dependent ligation (MLPA)?|<center>[[]]</center>}} | ||
{{hidden|What is fragment analysis?|<center>[[ | {{hidden|What is fragment analysis?|<center>[[]]</center>}} | ||
{{hidden|Compare and contrast RT-PCR vs qRTPCR.|<center>[[ | {{hidden|Compare and contrast RT-PCR vs qRTPCR.|<center>[[]]</center>}} | ||
{{hidden|What is MSI?|<center>[[ | {{hidden|What is MSI?|<center>[[]]</center>}} | ||
{{hidden|What is methylation analysis?|<center>[[ | {{hidden|What is methylation analysis?|<center>[[]]</center>}} | ||
===UNIT 5=== | ===UNIT 5=== | ||
{{hidden|What are the four test features required to be documented by the CLIA?|<center>[[ | {{hidden|What are the four test features required to be documented by the CLIA?|<center>[[]]</center>}} | ||
{{hidden|What are "in vitro diagnostics" vs "laboratory developed tests"?|<center>[[Microsatellite instability]]</center>}} | {{hidden|What are "in vitro diagnostics" vs "laboratory developed tests"?|<center>[[Microsatellite instability]]</center>}} |
Latest revision as of 00:23, 28 July 2015
UNIT 1
List three differences between DNA and RNA.
|
---|
DNA (double stranded, thymine, deoxyribose, more stable; RNA single stranded, ribose, uracil |
What are the three stop codons?
|
---|
[UAA, UGA, UAG]] |
Where does transcription begin?
|
---|
List 2 enzymes necessary for transcription and their function.
|
---|
List and describe three post transcription modifications of RNA.
|
---|
Why is alternative splicing important?
|
---|
List three differences between somatic and germline mutations.
|
---|
|
What is the difference between a missense and a non-sense mutation?
|
---|
|
Define a frameshift mutation.
|
---|
|
Why are inversion mutations difficult to detect?
|
---|
|
Describe the potential sequelae of a translocation mutation.
|
---|
|
UNIT 2
Translate the following: c.1524_1527delCGTA.
|
---|
|
List 5 features of SNPs.
|
---|
[[Most common DNA sequence variation in humans, must occur in >=1% of a particular population, frequency of SNPs varies by groups, but responsible for >90% of human genetic variation, an can be found in any region of genome]] |
Define a regulatory SNP versus a synonymous SNP?
|
---|
What is the difference between a microstalellite and a minisattelite?
|
---|
|
Describe Hardy-Weinberg Equilibrium?
|
---|
|
What factors can disrupt the H-W equilibrium?
|
---|
|
UNIT 3
What are the three major steps of PCR?
|
---|
|
What is the hallmark of PCR?
|
---|
|
What factors affect the method of genotyping chosen?
|
---|
|
Define sensitivity, specificity, positive predictive value and negative predictive value.
|
---|
|
Define reproduciblity and accuracy of an analytical test.
|
---|
|
Describe briefly how Taqman automated genotyping is used for allele detection.
|
---|
|
How are DNA microarrays used to identify drug disposition or responses?
|
---|
|
UNIT 4
Describe the procedure for submitting FFPE slides for KRAS for colorectal cancer.
|
---|
|
Compare and contrast uniplex versus multiplex genotyping.
|
---|
|
Compare and contrast conventional vs massively parallel sequencing.
|
---|
|
What is multiplex ligation-dependent ligation (MLPA)?
|
---|
|
What is fragment analysis?
|
---|
|
Compare and contrast RT-PCR vs qRTPCR.
|
---|
|
What is MSI?
|
---|
|
What is methylation analysis?
|
---|
|
UNIT 5
What are the four test features required to be documented by the CLIA?
|
---|
|
What are "in vitro diagnostics" vs "laboratory developed tests"?
|
---|
|
What does validation mean?
|
---|
|
What are the four performance characteristics that need to be verified for FDA cleared/approved tests?
|
---|
|
What are the six performance characteristics that need to be verified for FDA cleared LDTs or modified FDA cleared/approved tests?
|
---|
|
UNIT 6
List the components of a molecular pathology report.
|
---|
|
Define analytical sensitivity and clinical sensitivity.
|
---|
|
What should be said in a report of a molecular test on a patient for residual disease if no previous positive assay was confirmed?
|
---|
|
Define ammended report versus addendum report.
|
---|
|
Whose responsibility is it to sythesize the test results with other clinico-pathological information?
|
---|
|
How long are cytogenetic reports required to be kept by CAP?
|
---|
|
What is the recommended process to use test results if an assay is not yet validated for clinical use?
|
---|
|
Give three examples of "grey areas" which warrant discretion of professionals involved to use a non-validated test?
|
---|
|
What reference standard is available for gene nomenclature?
|
---|
|
Create a table of the most common gene rearrangements associated with heme and soft tissue diseases.
|
---|
|
What is a "DNA fingerprint" and what can it be used for?
|
---|
|